Objective: medication-related problems (MRP) are common for older adults and can lead to harm. The older person's perspective on MRP has been seldom reported in published literature. This study explored the lived experience of MRP in older adults with varying functional levels, focussing on the hospital discharge period. Design, setting, participants: this qualitative study was conducted in Brighton and Hove, UK. A purposive sample of 20 older people with experience of MRP, involving carers, took part in focus groups and semi-structured interviews. Data were thematically analysed using a 'framework' approach. Results: four major themes associated with MRP were identified; (1) experience of the healthcare system, (2) practicalities of using medicines, (3) management of medication problems and (4) participant beliefs. Participants encountered problems in communication with healthcare professionals such as passive listening and paternalistic consultations. A conflict was acknowledged between participants' implicit trust in the healthcare system and their negative experience of MRP. Participants felt vulnerable around hospital discharge, describing reduced capacity to comprehend information, pressured discharge circumstances and lack of integrated care in the community. Drug formulations, packaging and information leaflets were felt to be poorly tailored to the needs of older people. Conclusions: the lived experience of older people with MRP in this study was multifaceted and complex. Participants felt communication was poor around hospital discharge, and insufficient support with medicines was offered in the community when problems arose. Harm due to MRP might be reduced if the contributory factors described by patients inform clinical and policy-level intervention.
Introduction
Polypharmacy and medication-related harm are increasing in the UK [1, 2] . The period following hospital discharge is a time when older people are at highest risk; one in three experience medication-related harm within 8 weeks postdischarge [3] .
Although medication-related problems (MRP) are an important cause of harm, there has been little research to understand its impact from the older person's view point.
The patient perspective is crucial in effectively translating clinical research to 'real-world' settings [4, 5] . For instance, in the Canadian EMPOWER trial of patient education to support withdrawal of benzodiazepines in older users [6] , the patient perspective was pivotal to understand the patientprovider context necessary for successful deprescribing [7] .
The aim of this study was to explore the lived experience of MRP amongst older adults in a UK community setting. Given the increased risk of MRP following hospital discharge, we designed the study to elicit participant views around this critical time.
Methods
Full methods are described in Appendix A, available in Age and Ageing online. Three focus groups and eight semistructured interviews were conducted using topic guides with a purposive sample including both independent and housebound older adults in Brighton and Hove, UK. Participants were recruited through Age-UK Brighton and Hove (AUKBH). Data collection took place between October 2016 and January 2017 until data saturation (defined as no new themes being elicited) [8] . Data were analysed thematically using a Framework approach, developed by the National Centre for Social Research, particularly suited to multidisciplinary research teams [9, 10] . This approach involves five processes: data familiarisation, coding, indexing, charting, and interpretation.
Results

Participants
Twenty participants were included (see Appendix B, available in Age and Ageing online), 14 females, median age 78 years (range 65-98 years), all Caucasian. Twelve independent older adults, recruited from AUKBH activity groups, participated in three focus groups. The remaining eight participants (six housebound individuals and two informal carers) were recruited from a support service offered by AUKBH for recently discharged patients and interviewed at home.
The mean number of prescribed medicines amongst all participants was 5 (SD ±3.6, range 0-12). However, the mean was eight medicines amongst housebound individuals. Nine participants had a hospital admission in the past year.
Key findings
Participants' experience of MRP around hospital discharge is summarised in Figure 1 . The range of 'side-effects' described can be seen in Appendix 3, available in Age and Ageing online.
Four major themes associated with MRP were identified: experience of the healthcare system, practicalities of using medicines, management of medication problems and participant beliefs (see Table 1 ).
Experience of the healthcare system
Participants reported poor communication with health professionals and between professionals. In some cases, participants described passive listening and failure of doctors to respond when harm was reported. Discussion about MRP with General Practitioners (GP) often took place over the telephone due to lack of face-to-face appointments, limiting the quality of communication and capacity of GPs to fully address the problem. None of the participants felt involved in medication-related decisions. In response to adverse events, some participants reported changes in their own behaviour (e.g. asking a standard set of questions about any new medicine), to ensure they understand the rationale for medication-related decisions.
The transition from hospital to home was considered a particularly vulnerable time due to ongoing recovery from 
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illness, a reduced capacity to retain information provided at the point of discharge, and a lack of community follow-up. Changes made to regular medicines whilst in hospital contributed to participants' confusion and poor adherence when back in their own homes. Pharmacists were mentioned as a valuable support in the community, offering more time compared to GPs about medication-related concerns, and identifying prescribing errors.
Practicalities of using medicines
Many participants experienced difficulties with medicine formulation, packaging and/or instructions. They felt that medicines themselves were not tailored to meet the needs of an older person, with tablets such as aspirin being too small to handle and other medicines such as calcium/vitamin D combinations being too large to swallow. These problems were especially noted in the context of impaired vision or manual dexterity. One participant made the analogy between such difficulties in older people and that seen in children, '…imagine giving a big pill like that to a kid'.
Medication compliance aids (MCA), e.g. blister packs, were broadly felt to be helpful despite difficulties removing tablets which sometimes necessitated use of sharp instruments to cut into each pocket. A major concern was the inconsistency in the colour and shape of medicines placed in the MCAs from one week to another. Other challenges included packaging in foreign languages and discrepancies in the listed drug interactions for the same drug from different manufacturers.
Management of medication problems
Whilst some participants sought medical attention for MRP, many chose not to due to perceived lack of time of the GP, or, fear of being a 'nuisance'. Self-management of MRP was attempted using medical books, the online British National Formulary, newspapers articles, and the advice of friends or family. 'Trial and error' adjustment of medicines to overcome adverse effects, without consulting prescribers, was a common approach. One lady expressed the need to suffer side-effects as her 'body had to get used to it'.
Participant beliefs
A prominent sub-theme was the older person's misinformed risk to benefit calculations, with several participants describing a poorer quality of life due to MRP as a necessary trade-off for additional life years. Poor communication 'I kept telling her (General Practitioner) I was getting more and more suicidal, I told her, and then all she said was 'oh well, you've had these depressive states before', which was nothing at all to do with these tablets (steroids), this was something different' [P20, female, 84] 'When you're in hospital and you get prescribed these pills they don't ever tell you what they are and what they're for… they discuss things themselves and the patient is not involved, which is wrong…it's like a secret society' [P17, male, 75] Inappropriate prescribing 'They'll go back to the doctor and maybe see someone different and then say 'oh I've got this wrong with me' and they might be given another drug but it's not looked at that it might be the first drug that's causing that problem.' [P4, female, 69] Hospital discharge support 'I come out and they give me a pile of medicine to take which I didn't know what to do with and I had to get somebody, don't know what it was, come around and sort out medicine for me… that was that, and that's for afternoon and two of them, you know, 'cos I didn't know' [P14, male, 82] 'The pharmacist came around and talked to her about it and explained it and everything, she was going to change one of the medicines, so she had a good story before she came out of hospital' 'They're telling you you know nothing, whereas you're living it (medication problems) and you do know' [P1, female, 79]
'They must help if the doctor gives them to you': a qualitative study of the older person's lived experience of medication-related problems
There was a tension between the participants' expectations of medical treatment, based on implicit trust in their doctors, and their adverse lived experiences. One participant said 'they must help if the doctor gives them to you…but they're not, not in my body'.
Discussion
To our knowledge, this is the first community-based study in the UK to explore the lived experience of older people with MRP. This study highlights key challenges associated with MRP that concern patients; poor communication with prescribers, vulnerability during the transition of care at hospital discharge, inconsistency in medicines information and packaging, side-effects, and difficulties obtaining medical advice. We acknowledge that our findings were based on the views of a Caucasian cohort in one UK city.
Many of the practical problems with medication use highlighted in our study are common to older people in other European countries [11] . The dispensing of medicines packaged in part English and part foreign text, and inconsistent drug safety information between manufacturers are new insights. 'Parallel imports', where medicines are imported from countries outside of the UK and then sold and dispensed in the UK under a license from the Medicines and Healthcare products Regulatory Agency (MHRA), are used by pharmacies to reduce their purchase costs [12] . Our findings suggest that this is confusing and anxiety-provoking for some older people, and the MHRA should consider how to tighten regulations around relabelling to increase clarity for consumers. Furthermore, product safety information should be standardised between manufacturers of the same drug.
Participants reflected that doctors did not actively listen to their concerns of MRP, which directly led to harm in some instances. A Dutch study of hospitalised patients found that approximately 80% of patient reports of 'sideeffects' are accurate [13] . Thus a passive approach towards patient concerns of MRP is not clinically justifiable. The impact of medication harm extends beyond the physical discomfort; older people in this study described erosion of their trust in the healthcare system and heightened anxiety about future medicines use. The time taken in the short-term to elicit patient concerns and proactively respond to these could save substantially on time and cost required in the longer term to address poor adherence and medication harm.
The patient-prescriber relationship is a key determinant of safe and effective medicines use [14] . Concordance is a patient-centred approach to consultation which gives primacy to the patient perspective within negotiated medicationrelated decisions [15] . This approach re-orientates communication from paternalistic consultation, as experienced by our participants, to collaboration and consensus-built decisions which can better meet both the patient and provider's expectations of treatment [15, 16] .
Adequate information provision is crucial to shared decision making [17] and informed consent to treatment. Doctors struggle with the balance required in providing sufficient information of potential medication risk and causing undue fear [18] [19] [20] . Older people in this study sought clear and contextualised information at their level of comprehension of the medicine indication, and an open discussion of the potential risks and benefits for them as individuals. Our findings can generate a wider impact by supporting the case for enhanced medication counselling during pharmacist-led medication reviews at hospital discharge [21] . This would align with related national guidance [14, 22] , and might lead to reduction in MRP.
Conclusions
Older people describe a heightened vulnerability to MRP around hospital discharge, and identify inadequate communication, uncoordinated processes, inappropriate prescribing, and poor drug formulation and packaging as important issues to address.
Key points
• Comprehension of medicines-related information at hospital discharge is limited amongst older adults.
• Medication-related problems can erode the trust of patients in their doctors and the healthcare system. • Non-adherence is used by some older adults as a protective measure to ameliorate medication-related harm.
• Medicines formulation and information should be better tailored to the needs of older people.
• Older adults identify the transition around hospital discharge as high-risk for medication-related problems.
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